Shell is reportedly exploring a potential sale of its chemicals assets in Europe and the U.S., according to the Wall Street Journal, citing sources familiar with the matter. The energy giant has engaged Morgan Stanley to conduct a strategic review of its chemicals operations.
Potential buyers could include private equity firms and Middle Eastern companies looking to expand in Western markets. The review is still in its early stages, and Shell has not made any final decisions. Among the assets being assessed is the Deer Park facility in Texas, located next to a refinery Shell sold to Pemex, Mexico’s state oil company.
This move follows Shell’s 2023 sale of its refining and chemicals hub in Singapore, one of the world's largest. The company has been restructuring under CEO Wael Sawan, prioritizing its most profitable sectors—oil, gas, and biofuels—while scaling back on renewables. Earlier this year, Shell warned of lower earnings in its chemicals and oil products division due to reduced seasonal demand.
In December, Reuters reported that Shell was stepping back from new offshore wind investments and restructuring its power division, which was once central to its energy transition strategy.
Shell and Morgan Stanley declined to comment on the potential asset sales.


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Instagram Outage Disrupts Thousands of U.S. Users
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



